Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
OIL
vs
S
S&P/ASX 300
OIL
Over the past 12 months, OIL has significantly outperformed S&P/ASX 300, delivering a return of +28% compared to S&P/ASX 300's 2% drop.
Stocks Performance
OIL vs S&P/ASX 300
Performance Gap
OIL vs S&P/ASX 300
Performance By Year
OIL vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Optiscan Imaging Ltd
Glance View
Optiscan Imaging Ltd makes high-resolution digital microscopy systems for healthcare and life sciences. Its core product is an optical imaging technology that lets doctors and researchers view tissue at cell-level detail without cutting it into traditional glass slides first. The company sells the imaging hardware, software, and related support needed to capture and analyze those images. Its main customers are hospitals, surgeons, pathology labs, medical device partners, and research groups. In medicine, the technology is aimed at helping doctors examine tissue during surgery or in diagnostic workflows. In research and drug development, it is used to study tissue samples and biological processes in a more immediate, digital form. Optiscan makes money by selling imaging systems, software, and related service or licensing arrangements tied to its technology. What makes its business model distinctive is that it sits at the point where surgery, pathology, and digital imaging meet: instead of shipping tissue away for delayed lab work, it helps turn microscopic tissue review into a live digital process. That gives the company a role as a specialized technology supplier to the medical imaging chain rather than a broad hospital equipment maker.
